Erratum to Barco et al. "Home treatment of patients with lowrisk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the Hot-PE Trial" (Thromb Haemost 2016; 116: 191-197)

Thromb Haemost. 2016 Sep 27;116(4):775. doi: 10.1160/TH16100001.

Abstract

[This corrects the article DOI: 10.1160/TH16-01-0004.].

Publication types

  • Published Erratum